Romain Olekhnovitch, PhD

  • 2Articles
  • 12.6KReads
  • 2018–2022Active
  • 16Collaborators
  • 17Citations

About

Romain Olekhnovitch, PhD, is affiliated with the Population-based Epidemiological Cohorts Unit, UMS 011 Inserm-UVSQ in Villejuif, France. Olekhnovitch has published research on major depressive disorder, focusing on topics such as the acceptability of second-line antidepressant medications and the relationship between depression, cognitive functions, and impaired functioning in middle-aged adults. Collaborators frequently include Cédric Lemogne, Frédéric Limosin, Nicolas Hoertel, Antoine Rachas, and Carlos Blanco.

Publications

JCP
Acceptability of Second-Line Antidepressant Medications
Original Research

Acceptability of Second-Line Antidepressant Medications

October 17, 2022

Second-line antidepressant options were ranked according to acceptability (efficacy and tolerability), using data from the French health system.
, , , et al
JCP
Original Research

Depression, Cognition, and Functional Impairment

November 13, 2018

Depression is strongly associated with functional impairment. Some hypothesize that cognitive dysfunction, which is also often associated with depression, might mediate the impact of depression on functioning. This study...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe